Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Leong; Kahan
Address:
Playa Del Rey, CA
No. of patents:
19
Patents:












Patent Number Title Of Patent Date Issued
8003758 BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer c August 23, 2011
Described is a novel gene and its encoded secreted tumor antigen, termed BPC-1, and to diagnostic and therapeutic methods and compositions useful in the management of various cancers which express BPC-1, particularly including prostate cancer and bladder cancer. In human normal tissues,
7981624 Methods to detect tumors using 20P1F12/TMPRSS2 expression July 19, 2011
Compositions for the diagnosis and therapy of prostate and colon cancer, derived from or based on a novel prostate-specific, androgen-regulated, cell membrane associated and secreted serine protease termed 20P1F12/TMPRSS2 are described. A full length cDNA comprising the entire coding
7968307 Serpentine transmembrane antigens expressed in human cancers and uses thereof June 28, 2011
Described is a novel family of cell surface serpentine transmembrane antigens. Two of the proteins in this family are exclusively or predominantly expressed in the prostate, as well as in prostate cancer, and thus members of this family have been termed "STEAP" (Six Transmembrane Epi
7928201 Serpentine transmembrane antigens expressed in human cancers and uses thereof April 19, 2011
Described is a novel family of cell surface serpentine transmembrane antigens. Two of the proteins in this family are exclusively or predominantly expressed in the prostate, as well as in prostate cancer, and thus members of this family have been termed "STEAP" (Six Transmembrane Epi
7858760 Antibodies to protein expressed in prostate cancer December 28, 2010
A novel prostate tumor associated gene (designated 24P4C12) and its encoded protein is described. 24P4C12 is highly expressed in prostate tissue xenografts, providing evidence that it is turned on in at least some prostate cancers. 24P4C12 provides a diagnostic and/or therapeutic tar
7785811 BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer c August 31, 2010
Described is a novel gene and its encoded secreted tumor antigen, termed BPC-1, and to diagnostic and therapeutic methods and compositions useful in the management of various cancers which express BPC-1, particularly including prostate cancer and bladder cancer. In human normal tissues,
7642054 Serpentine transmembrane antigens expressed in human cancers and uses thereof January 5, 2010
Described is a novel family of cell surface serpentine transmembrane antigens. Two of the proteins in this family are exclusively or predominantly expressed in the prostate, as well as in prostate cancer, and thus members of this family have been termed "STRAP" Serpentine TRansmembra
7611904 Serpentine transmembrane antigens expressed in human cancers and uses thereof November 3, 2009
Described is a novel family of cell surface serpentine transmembrane antigens. Two of the proteins in this family are exclusively or predominantly expressed in the prostate, as well as in prostate cancer, and thus members of this family have been termed "STEAP" (SIX Transmembrane Epi
7575749 Serpentine transmembrane antigens expressed in human cancers and uses thereof August 18, 2009
Described is a novel family of cell surface serpentine transmembrane antigens. Two of the proteins in this family are exclusively or predominantly expressed in the prostate, as well as in prostate cancer, and thus members of this family have been termed "STEAP" (Six Transmembrane Epi
7306796 13-transmembrane protein expressed in prostate cancer December 11, 2007
A novel prostate tumor associated gene (designated 24P4C12) and its encoded protein is described. 24P4C12 is highly expressed in prostate tissue xenografts, providing evidence that it is turned on in at least some prostate cancers. 24P4C12 provides a diagnostic and/or therapeutic tar
7227008 13-transmembrane protein expressed in prostate cancer June 5, 2007
A novel prostate tumor associated gene (designated 24P4C12) and its encoded protein is described. 24P4C12 is highly expressed in prostate tissue xenografts, providing evidence that it is turned on in at least some prostate cancers. 24P4C12 provides a diagnostic and/or therapeutic tar
7220823 Transmembrane protein expressed in prostate and other cancers May 22, 2007
A novel prostate tumor associated gene (designated 24P4C12) and its encoded protein is described. 24P4C12 is highly expressed in prostate tissue xenografts, providing evidence that it is turned on in at least some prostate cancers. 24P4C12 provides a diagnostic and/or therapeutic tar
7166714 Serpentine transmembrane antigens expressed in human cancers and uses thereof January 23, 2007
Described is a novel family of cell surface serpentine transmembrane antigens. Two of the proteins in this family are exclusively or predominantly expressed in the prostate, as well as in prostate cancer, and thus members of this family have been termed "STEAP" (Six Transmembrane Epi
7053186 Antibodies immunospecific for STEAP1 May 30, 2006
Described is a novel family of cell surface serpentine transmembrane antigens. Two of the proteins in this family are exclusively or predominantly expressed in the prostate, as well as in prostate cancer, and thus members of this family have been termed "STRAP" (serpentine transmembr
7037667 Tumor antigen useful in diagnosis and therapy of prostate and colon cancer May 2, 2006
Compositions for the diagnosis and therapy of prostate and colon cancer, derived from or based on a novel prostate-specific, androgen-related, cell membrane associated and secreted serine protease termed 20P1F12/TMPRSS2 are described. A full length cDNA comprising the entire coding s
6943235 Transmembrane protein expressed in prostate cancer September 13, 2005
A novel prostate tumor associated gene (designated 24P4C12) and its encoded protein is described. 24PC12 is highly expressed in prostate tissue xenografts, providing evidence that it is turned on in at least some prostate cancers. 24P4C12 provides a diagnostic and/or therapeutic target
6887975 Peptides derived from STEAP1 May 3, 2005
Described is a novel family of cell surface serpentine transmembrane antigens. Two of the proteins in this family are exclusively or predominantly expressed in the prostate, as well as in prostate cancer, and thus members of this family have been termed "STEAP" (serpentine transmembr
6329503 Serpentine transmembrane antigens expressed in human cancers and uses thereof December 11, 2001
Described is a novel family of cell surface serpentine transmembrane antigens. Two of the proteins in this family are exclusively or predominantly expressed in the prostate, as well as in prostate cancer, and thus members of this family have been termed "STEAP" (Six Transmembrane Epi
6277972 BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer c August 21, 2001
Described is a novel gene and its encoded secreted tumor antigen, termed BPC-1, and to diagnostic and therapeutic methods and compositions useful in the management of various cancers which express BPC-1, particularly including prostate cancer and bladder cancer. In human normal tissues,










 
 
  Recently Added Patents
System and method for measuring an analyte in a sample
Device and method to automatically configure port forwarding
Electron beam manipulation system and method in X-ray sources
Interconnect, bus system with interconnect and bus system operating method
Electronic dispersion compensation within optical communications using reconstruction
Vehicle front fender
Eyeglasses
  Randomly Featured Patents
High-temperature Ni-MH battery and a method for making the same
Image heating apparatus with energization control
Lid and door for a vacuum chamber and pretreatment therefor
Substrate processing apparatus for processing plurality of substrates in succession
Nail magazine
Plating concentrate
Reduction of oxides in a fluid-based switch
Markings for contact lenses
Auxiliary table for extension and repositioning in medical operations
Method of detecting analytes in a microfluidic sample and a system for performing the same